Ingela Fehrman-Ekholm
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Urwyler P, Leimbacher M, Charitos P, Moser S, Fehrman-Ekholm I, Trendelenburg M, Thoma R, Sumer J, Camacho-Ortiz A, Bacci M, Huber L, Stüssi-Helbling M, Albrich W, Sendi P, Osthoff M. Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial. Front Immunol 2023; 14:1255292.
Oct 27, 2023Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial.
Oct 27, 2023Front Immunol 2023; 14:1255292
Urwyler Pascal, Leimbacher Marina, Charitos Panteleimon, Moser Stephan, Fehrman-Ekholm Ingela, Trendelenburg Marten, Thoma Reto, Sumer Johannes, Camacho-Ortiz Adrián, Bacci Marcelo R, Huber Lars Chistian, Stüssi-Helbling Melina, Albrich Werner, Sendi Parham, Osthoff Michael
Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017
Legendre C, Kuypers D, Schwenger V, Binet F, Diekmann F, Epailly E, O'Grady J, Wennberg L, Potena L, Berenguer M, Masnou N, Fehrman-Ekholm I, Viebahn R, Guthoff M. Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017. Transplantation 2018; 102:S1-S14.
Sep 1, 2018Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017
Sep 1, 2018Transplantation 2018; 102:S1-S14
Legendre Christophe, Kuypers Dirk, Schwenger Vedat, Binet Françoise-Isabelle, Diekmann Fritz, Epailly Eric, O'Grady John, Wennberg Lars, Potena Luciano, Berenguer Marina, Masnou Núria, Fehrman-Ekholm Ingela, Viebahn Richard, Guthoff Martina